Abstract Conversion of γ-hydroxybutyric acid (GHB) to a fluorescent derivative using 3-bromomethyl-6,7-dimethoxy-1-methyl-1,2-dihydroquinoxaline-2-one
(Br-DMEQ), and its application to drug screening were studied. Br-DMEQ reacted with the carboxyl group of sodium GHB in the
presence of a potassium salt and crown ether to produce a fluorescent derivative, which could be easily detected by thin-layer
chromatography (TLC). An electrospray ionization mass spectrum of the fluorogenic product supported the expected structure.
The Br-DMEQ-derivatized GHB gave an Rf value of 0.49 on TLC, which was easily distinguished from 19 other carboxylic acids;
all of the latter had Rf values over 0.61. Various sodium carboxylates including sodium GHB reacted with Br-DMEQ in the presence
of KCl, but the free forms of the carboxylic acids did not react under these conditions. When aqueous solution containing
GHB was pretreated with sulfuric acid, GHB was converted to γ-butyrolactone, resulting in removal of its reactivity with Br-DMEQ.
By such analysis following the derivatization, with and without the above pre-treatment with sulfuric acid, GHB added to human
urine could be specifically detected, although the limit of detection was about 100μg/ml, which was 20 times higher than the
endogenous blood GHB level. Therefore, the present method seems useful for screening GHB present in a solid state such as
powder and tablets, and also in urine samples obtained in overdose cases.
Content TypeJournal Article
JournalForensic ToxicologyOnline ISSN 1860-8973Print ISSN 1860-8965
Journal VolumeVolume 24
Journal IssueVolume 24, Number 1 / July, 2006 (Source: Forensic Toxicology)